BKS Finance Baltic OÜ
- Registry code
- 14269013
- VAT number
- EE102122048
- Address
- Harju maakond, Tallinn, Kesklinna linnaosa, Ahtri tn 6a, 10151
- Registered
- 30.05.2017 · 9 yrs
- Activity
- Wholesale of pharmaceutical goods 46461
- Additional activities
- Non-specialised wholesale trade
- Capital
- 3 000 €
- b•••@g•••.comLog in to see
- Phone
- +372 5•• ••••Log in to see
- No tax debt
- No enforcement proceedings (12 months)
- No payment orders (12 months)
- No bankruptcy or liquidation
- No sanctions
- Report filed (2025)
- VAT registered
Add the rating badge to your website
The badge code is available to this company's verified account: verification uses a code we send to the company email in the Business Register. The badge updates itself and cannot be bought. Read more
Board and owners
1 persons
| Board 1 | ||
|---|---|---|
| Olena Kovalova2 companiesno tax debt | Personal ID ↗ | 17.09.2020 |
| Shareholders 1 | ||
| Oksana Baskakova | 100,0% 3 000 € | 02.09.2023 |
| Beneficial owners 1 | ||
| OKSANA BASKAKOVAdirect holding | 19.09.2018 | |
Business Register open data
Quarterly taxes and revenue
2026 Q2
2026 Q2. Wage is estimated from employment taxes.
| Quarter | Revenue | Change y/y | Labour taxes | State taxes | Employees |
|---|---|---|---|---|---|
| 2026 Q2 | 10 700 € | ▲ 30% | 1 110 € | 1 071 € | — |
| 2026 Q1 | 11 550 € | ▲ 182% | 1 110 € | 1 071 € | — |
| 2025 Q4 | 8 260 € | ▼ 39% | 1 110 € | 1 071 € | — |
| 2025 Q3 | 7 293 € | ▼ 41% | 1 110 € | 1 071 € | — |
| 2025 Q2 | 8 250 € | ▲ 62% | 1 110 € | 1 071 € | — |
| 2025 Q1 | 4 100 € | ▼ 59% | 1 088 € | 1 049 € | — |
| 2024 Q4 | 13 450 € | ▲ 10% | 1 045 € | 6 006 € | — |
| 2024 Q3 | 12 398 € | ▲ 65% | 1 045 € | 4 756 € | — |
| 2024 Q2 | 5 100 € | ▼ 71% | 2 911 € | 14 297 € | — |
| 2024 Q1 | 10 085 € | ▲ 36% | 321 € | 303 € | — |
| 2023 Q4 | 12 250 € | ▲ 132% | 321 € | 303 € | — |
| 2023 Q3 | 7 500 € | ▲ 156% | 321 € | 303 € | — |
Show full history (18 quarters)
| 2023 Q2 | 17 565 € | ▲ 185% | 1 512 € | 10 316 € | — |
| 2023 Q1 | 7 400 € | ▼ 97% | 761 € | 720 € | — |
| 2022 Q4 | 5 290 € | 870 € | 827 € | — | |
| 2022 Q3 | 2 930 € | 870 € | 827 € | — | |
| 2022 Q2 | 6 163 € | 1 118 € | 1 071 € | — | |
| 2022 Q1 | 216 080 € | 940 € | 10 968 € | — |
Tax and Customs Board, published on the 10th of the month following the quarter. State taxes include employment taxes. CC BY-SA 3.0
Annual reports
5 yr
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Sales revenue | 179 k € | ▼ 83% | 1,1 m € | ▲ 34% | 805 k € | ▲ 2% | 787 k € | ▼ 73% | 2,9 m € |
| Profit | -439 k € | ▼ into loss | 994 k € | ▲ into profit | -646 k € | ▼ 98% | -327 k € | ▼ 399% | -65 433 € |
| Profit margin | -245,7% | 91,9% | -80,3% | -41,5% | -2,3% | ||||
| Retained earnings | 1,6 m € | ▲ 155% | 640 k € | ▼ 54% | 1,4 m € | ▲ 74% | 790 k € | ▼ 12% | 895 k € |
| Cash | 91 460 € | ▲ 28% | 71 655 € | ▼ 87% | 562 k € | ▲ 584% | 82 158 € | ▼ 45% | 148 k € |
| Current assets | 1,7 m € | ▼ 26% | 2,2 m € | ▼ 3% | 2,3 m € | ▲ 112% | 1,1 m € | ▼ 59% | 2,7 m € |
| Fixed assets | — | — | 0 € | ▼ 100% | 401 k € | 0% | 401 k € | ||
| Assets | 1,7 m € | ▼ 26% | 2,2 m € | ▼ 3% | 2,3 m € | ▲ 55% | 1,5 m € | ▼ 51% | 3,1 m € |
| Current liabilities | 454 k € | ▼ 23% | 592 k € | ▼ 62% | 1,6 m € | ▲ 53% | 1,0 m € | ▼ 54% | 2,2 m € |
| Long-term liabilities | — | — | 0 € | 0 € | 0 € | ||||
| Total liabilities | 454 k € | ▼ 23% | 592 k € | ▼ 62% | 1,6 m € | ▲ 53% | 1,0 m € | ▼ 54% | 2,2 m € |
| Equity | 1,2 m € | ▼ 27% | 1,6 m € | ▲ 123% | 735 k € | ▲ 58% | 466 k € | ▼ 44% | 833 k € |
| Labour costs | -10 439 € | ▼ 7% | -9 759 € | ▼ 54% | -6 352 € | ▲ 45% | -11 594 € | ▼ 2% | -11 400 € |
| Employees | 1 | 0% | 1 | 0% | 1 | 0% | 1 | 0% | 1 |
| Filed | 31.08.2026 | 21.04.2025 | 08.04.2024 | 26.07.2023 | 22.07.2022 | ||||
| Report | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ | PDF ↓ |
▲ growth, ▼ decline compared to the previous year (growth in liabilities is red). Business Register, annual reports. CC BY 4.0
Revenue by activity
2025
| Activity | EMTAK | Sales revenue | Osa |
|---|---|---|---|
| Wholesale of pharmaceutical goods main activity | 46461 | 160 957 € | 90% |
| Non-specialised wholesale trade | 46901 | 17 884 € | 10% |
2025 annual report, RIK open data
Real estate
e-kinnistusraamat
Loading properties…
Source: e-kinnistusraamat (Centre of Registers and Information Systems), basic data
Debts and court cases
clean
Tax Board debtor list (daily), Official Announcements, State Gazette. The Tax Board publishes only today's list; earlier history is collected by Firmo.
Enforcement, payment orders and notices
clean
Official Announcements contain no enforcement, payment order or tax authority notices about the company.
Official Announcements (CC BY-SA 4.0). Enforcement proceedings, payment orders or tax decisions are published there only if they cannot be delivered to the company otherwise. The enforcement register is not public, so the absence of a notice does not mean there are no claims.
State: transactions, tenders, grants
none
No transactions with state agencies, procurement contracts or grants found
RTK Saldo, Riigihangete register, RTK toetatud projektid
Holdings in other companies
0
No holdings in other companies
Companies linked via the board
1
Sorted by revenue (latest report or 4 quarters).
Top 20 in activity: Wholesale of pharmaceutical goods
20
| # | Company | Revenue |
|---|---|---|
| 1 | MAGNUM MEDICAL OÜ | 295,0 m € |
| 2 | TAMRO EESTI OÜ | 239,6 m € |
| 3 | Novo Nordisk Estonia OÜ | 37,0 m € |
| 4 | SONA-PHARM OÜ | 36,9 m € |
| 5 | Boehringer Ingelheim RCV GmbH & Co KG Eesti filiaal | 30,7 m € |
| 6 | Aktsiaselts Magnum Veterinaaria | 28,6 m € |
| 7 | Osaühing Zoovetvaru | 21,5 m € |
| 8 | Osaühing Berlin-Chemie Menarini Eesti | 17,3 m € |
| 9 | Globalex Pharma OÜ | 16,1 m € |
| 10 | OÜ Micotrade | 15,8 m € |
| 11 | Apteegikaubanduse Hulgimüük OÜ | 12,2 m € |
| 12 | Aktsiaselts FORANS EESTI | 8,0 m € |
| 13 | DAAAK Pharma Int. AS | 7,6 m € |
| 14 | Gerdavit OÜ | 7,2 m € |
| 15 | AS Oribalt Tallinn | 7,0 m € |
| 16 | Aktsiaselts PAIRA | 6,2 m € |
| 17 | ORNYX OÜ | 5,1 m € |
| 18 | Pharm Origin OÜ | 5,1 m € |
| 19 | First Pharma OÜ | 4,9 m € |
| 20 | Hiirehernes OÜ | 4,8 m € |
Revenue from the latest annual report, otherwise Tax Board revenue for 4 quarters. All companies in this activity
Licences, pledges, domains
No data
History and notices
16
| Date | Type | Content |
|---|---|---|
| 02.09.2023 | Entry | Amendment entry |
| 03.05.2023 | Entry | Amendment entry |
| 18.04.2022 | Trahvihoiatusmäärus: majandusaasta aruanne esitamata | |
| 29.03.2022 | Entry | Amendment entry |
| 29.03.2022 | Order to remedy deficiencies | Amendment entry |
| 14.01.2021 | Entry | Amendment entry |
| 17.09.2020 | Entry | Amendment entry |
| 14.12.2018 | Entry | Muutmiskanne ÄS § 525 lg 2 alusel |
| 08.10.2018 | Entry | Amendment entry |
| 04.10.2018 | Administrative order | Amendment entry |
| 24.09.2018 | Entry | Amendment entry |
| 21.09.2018 | Entry | Amendment entry |
| 18.09.2018 | Entry | Amendment entry |
| 20.01.2018 | Entry | Amendment entry |
| 13.12.2017 | Entry | Amendment entry |
| 30.05.2017 | Entry | First entry |